Advanced search
Publication Cover
Gynecological Endocrinology Volume 35, 2019 - Issue 7
Submit an article Journal homepage
905
Views
24
CrossRef citations to date
0
Altmetric
DOES DOUBLE TRIGGER (GNRH AGONIST+ HCG) IMPROVE OUTCOME IN POOR RESPONDERS?

Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study

Jigal HaasDepartment of Obstetrics and Gynecology, Sheba Medical Center, Ramat-Gan, Israel; ;Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel;
,
Eran ZilberbergDepartment of Obstetrics and Gynecology, Sheba Medical Center, Ramat-Gan, Israel; ;Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel;
,
Ravit NahumDepartment of Obstetrics and Gynecology, Sheba Medical Center, Ramat-Gan, Israel; ;Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel;
,
Aya Mor SasonDepartment of Obstetrics and Gynecology, Sheba Medical Center, Ramat-Gan, Israel; ;Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel;
,
Ariel HourvitzDepartment of Obstetrics and Gynecology, Sheba Medical Center, Ramat-Gan, Israel; ;Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel;
,
Itai GatDepartment of Obstetrics and Gynecology, Sheba Medical Center, Ramat-Gan, Israel; ;Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel;
&
Raoul OrvietoDepartment of Obstetrics and Gynecology, Sheba Medical Center, Ramat-Gan, Israel; ;Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; ;The Tarnesby-Tarnowski Chair for Family Planning and Fertility Regulation, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, IsraelCorrespondence[email protected]
 show all
Pages 628-630 | Received 19 Nov 2018, Accepted 23 Dec 2018, Published online: 27 Feb 2019

References

  • Penzias AS. Improving results with assisted reproductive technologies: individualized patient-tailored strategies for ovulation induction. Reprod Biomed Online. 2004;9:43–46.
  • Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26:1616–1624.
  • Ben-Rafael Z, Orvieto R, Feldberg D. The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program. Gynecol Endocrinol. 1994;8:277–286.
  • Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril. 2000;73:667–676.
  • Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril. 2002;77:776–780.
  • Polyzos NP, Blockeel C, Verpoest W, et al. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod. 2012;27:3481–3486.
  • Orvieto R, Kruchkovich J, Rabinson J, et al. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs. Fertil Steril. 2008;90:228–230.
  • Kedem A, Tsur A, Haas J, et al. Is the modified natural in vitro fertilization cycle justified in patients with “genuine” poor response to controlled ovarian hyperstimulation? Fertil Steril. 2014;101:1624–1289.
  • Haas J, Zilberberg E, Kedem A, et al. Do poor-responder patients benefit from increasing the daily gonadotropin dose from 300 to 450 IU during controlled ovarian hyperstimulation for IVF? Harefuah. 2015;154:118–121.
  • Humaidan P, Chin W, Rogoff D, et al. ESPART study investigators. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders. Hum Reprod. 2017;32:544–555.
  • Orvieto R. Triggering final follicular maturation-hCG, GnRH-agonist or both, when and to whom? J Ovarian Res. 2015;8:60.
  • Lin MH, Wu FS, Lee RK, et al. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Fertil Steril. 2013;100:1296–1302.
  • Griffin D, Feinn R, Engmann L, et al. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates. Fertil Steril. 2014;102:405–409.
  • Haas J, Zilberberg E, Dar S, et al. Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles-a preliminary report. J Ovarian Res. 2014;7:77.
  • Zilberberg E, Haas J, Dar S, et al. Co-administration of GnRH-agonist and hCG for final oocyte maturation in patients with low proportion of mature oocytes. Gyn Endocrinol. 2015;31:145–147.
  • Orvieto R. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation. J Ovarian Res. 2015;8:69.
  • Ziebe S, Lundin K, Janssens R, et al. Arce JC for the MERIT. FSH on embryo quality parameters in patients undergoing IVF. Hum Reprod. 2007;22:2404–2413.
  • Ludwig M, Doody KJ, Doody KM. Use of recombinant human chorionic gonadotropin in ovulation induction. Fertil Steril. 2003;79:1051–1059.
  • Gonen Y, Balakier H, Powell W, Casper RF. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab. 1990;71:918–922.
  • Shapiro BS, Daneshmand ST, Garner FC, et al. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertil Steril. 2008;90:231–233.
  • Orvieto R. Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma. J Ovarian Res. 2013;6:77.
  • Beck-Fruchter R, Weiss A, Lavee M, et al. Empty follicle syndrome: successful treatment in a recurrent case and review of the literature. Hum Reprod. 2012;27:1357–1367.
  • Martinez F, Barri PN, Coroleu B, et al. Women with poor response to IVF have lowered circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spontaneous and stimulated cycles. Hum Reprod. 2002;17:634–640.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.